In the context of GVHD, innate immune activation promotes the production of stimulatory cytokines, such as IL‐12 and IL‐23, which facilitate the differentiation of donor T cells into various effector CD4+ T cell (Teff) lineages. The gene discussed is CD4; the disease is graft versus host disease.